Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders.

Drug Des Devel Ther · 2015 · PMC4389813 · PMID 25897202

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significanceP =0.057so close (0.05 < p ≤ 0.1)

For forearm pronators, the responder rate approached but did not reach statistical significance for incobotulinumtoxinA versus placebo ( P =0.057).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.